MicroRNAs (miRNAs) AS REGULATORS OF GENE EXPRESSION AND THEIR CLINICAL IMPORTANCE
DOI:
https://doi.org/10.19136/kuxulkab.a28n60.4657Keywords:
Noncoding RNA, Genetic regulation, BiomarkersAbstract
miRNAs are small non-coding endogenous RNAs that regulate gene expression and are involved in the development of various diseases; therefore, they are of therapeutic relevance. The objective of this work is to make known in a general way the role that miRNAs play in the development of diseases and their application as biomarkers. To do this, an observational study was carried out by searching the scientific literature using the PubMed database. The synthesis of the evidence shows us that the processes regulated by miRNAs and the identification of target genes in the development of diseases is a very valuable and exciting strategy that may eventually lead to the development of new treatment approaches.
Downloads
References
Angelopoulou, E.; Paudel, Y.N. & Piperi, C. (2019). miR-124 and Parkinson's disease: a biomarker with therapeutic potential. Pharmacol Res., (150): 104515. DOI «https://doi.org/10.1016/j.phrs.2019.104515» DOI: https://doi.org/10.1016/j.phrs.2019.104515
Atkin, S.L.; Ramachandran, V.; Yousri, N.A.; Benurwar, M.; Simper, S.C.; McKinlay, R.; Adams, T.D.; Najafi-Shoushtari, H. & Hunt, S.C. (2019). Changes in blood microRNA expression and early metabolic responsiveness 21 days following bariatric surgery. Frontiers in Endocrinology, 9: 773. DOI «https://doi.org/10.3389/fendo.2018.0077» DOI: https://doi.org/10.3389/fendo.2018.00773
Bartel, D.P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116(2): 281-297. DOI «https://doi.org/10.1016/S0092-8674(04)00045-5» DOI: https://doi.org/10.1016/S0092-8674(04)00045-5
Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A. & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer Journal for Clinicians, 68(6): 394-424. DOI «https://doi.org/10.3322/caac.21492» DOI: https://doi.org/10.3322/caac.21492
Budak, H.; Bulut, R.; Kantar, M. & Alptekin, B. (2016). MicroRNA nomenclature and the need for a revised naming prescription. Briefings in functional genomics, 15(1): 65–71. DOI «https://doi.org/10.1093/bfgp/elv026» DOI: https://doi.org/10.1093/bfgp/elv026
Canter, R.G.; Penney, J. & Tsai, L.H. (2016). The road to restoring neural circuits for the treatment of Alzheimer's disease. Nature, (539): 187-196. DOI «https://doi.org/10.1038/nature20412» DOI: https://doi.org/10.1038/nature20412
Churov, A.V.; Oleinik, E.K. & Knip, M. (2015). MicroRNAs in rheumatoid arthritis: altered expression and diagnostic potential. Autoimmunity Reviews, 14(11): 1029-1037. DOI «https://doi.org/10.1016/j.autrev.2015.07.005» DOI: https://doi.org/10.1016/j.autrev.2015.07.005
Cirillo, F.; Catellani, C.; Sartori, C.; Lazzeroni, P.; Amarri, S. & Street, M.E. (2019). Obesity, insulin resistance, and colorectal cancer: could miRNA dysregulation play a role?. International Journal of Molecular Sciences, 20(12): 2922. DOI «https://doi.org/10.3390/ijms20122922» DOI: https://doi.org/10.3390/ijms20122922
Cunningham, C.C.; Wade, S.; Floudas, A.; Orr, C.; McGarry, T.; Wade, S.; Cregan, S.; Fearon, U. & Veale, D.J. (2021). Serum miRNA signature in rheumatoid arthritis and 'At-Risk Individuals'. Frontiers in Immunology, 12: 633201. DOI «https://doi.org/10.3389/fimmu.2021.633201» DOI: https://doi.org/10.3389/fimmu.2021.633201
Denli, A.M.; Tops, B.B.J.; Plasterk, R.H.A.; Ketting, R.F. & Hannon, G.J. (2004). Processing of primary microRNAs by the Microprocessor complex. Nature, 432: 231-235. «https://doi.org/10.1038/nature03049» DOI: https://doi.org/10.1038/nature03049
Di Leva, G.; Garofalo, M. & Croce, C.M. (2014). MicroRNAs in cancer. Annual Review of Pathology, 9, 287-314. DOI «https://doi.org/10.1146/annurev-pathol-012513-104715» DOI: https://doi.org/10.1146/annurev-pathol-012513-104715
Du, H.; Zhao, Y.; Yin, Z.; Wang, D.W. & Chen, C. (2021). The role of miR-320 in glucose and lipid metabolism disorder-associated diseases. International Journal of Biological Sciences, 17(2): 402-416. DOI «https://doi.org/10.7150/ijbs.53419» DOI: https://doi.org/10.7150/ijbs.53419
Eddy, S.R. (2001). Non-coding RNA genes and the modern RNA world. Nature Reviews Genetics, 2: 919-929. DOI «https://doi.org/10.1038/35103511» DOI: https://doi.org/10.1038/35103511
Evangelatos, G.; Fragoulis, G.E.; Koulouri, V. & Lambrou, G.I. (2019). MicroRNAs in rheumatoid arthritis: from pathogenesis to clinical impact. Autoimmunity reviews, 18(11): 102391. DOI «https://doi.org/10.1016/j.autrev.2019.102391» DOI: https://doi.org/10.1016/j.autrev.2019.102391
Fukuda, T.; Itoh, M.; Ichikawa, T.; Washiyama, K. & Goto, Y. (2005). Delayed maturation of neuronal architecture and synaptogenesis in cerebral cortex of Mecp2-deficient mice. Journal of Neuropathology & Experimental Neurology, 64(6): 537-544. DOI «https://doi.org/10.1093/jnen/64.6.537» DOI: https://doi.org/10.1093/jnen/64.6.537
Goh, S.Y.; Chao, Y.X.; Dheen, S.T.; Tan, E.K. & Tay, S.S. (2019). Role of MicroRNAs in Parkinson's disease. International Journal of Molecular Sciences, 20(22): 5649. DOI «https://doi.org/10.3390/ijms20225649» DOI: https://doi.org/10.3390/ijms20225649
Ha, M. & Kim, V.N. (2014). Regulation of microRNA biogenesis. Nature Reviews Molecular Cell Biology, 15: 509-524. DOI «https://doi.org/10.1038/nrm3838» DOI: https://doi.org/10.1038/nrm3838
Han, J.; Lee, Y.; Yeom, K.H.; Kim, Y.K.; Jin, H. & Kim, V.N. (2004). The Drosha-DGCR8 complex in primary microRNA processing. Genes & development, 18(24): 3016-3027. DOI «https://doi.org/10.1101/gad.1262504» DOI: https://doi.org/10.1101/gad.1262504
Hanahan, D. & Weinberg, R.A. (2011). Hallmarks of cancer: the next generation. Cell, 144(5): 646-674. DOI «https://doi.org/10.1016/j.cell.2011.02.013» DOI: https://doi.org/10.1016/j.cell.2011.02.013
He, Z.; Xu, H.; Meng, Y. & Kuang, Y. (2017). miR-944 acts as a prognostic marker and promotes the tumor progression in endometrial cancer. Biomedicine & Pharmacotherapy, 88: 902-910. DOI «https://doi.org/10.1016/j.biopha.2017.01.117» DOI: https://doi.org/10.1016/j.biopha.2017.01.117
Heemels, M.T. (2016). Neurodegenerative diseases. Nature, 539: 179. DOI «https://doi.org/10.1038/539179a» DOI: https://doi.org/10.1038/539179a
Impey, S.; Davare, M.; Lasiek, A.; Fortin, D.; Ando, H.; Varlamova, O.; Obrietan, K.; Soderling, T.; Goodman, R.H. & Wayman, G.A. (2010). An activity-induced microRNA controls dendritic spine formation by regulating Rac1-PAK signaling. Molecular and Cellular Neuroscience, 43(1): 146-156. DOI «https://doi.org/10.1016/j.mcn.2009.10.005» DOI: https://doi.org/10.1016/j.mcn.2009.10.005
Iorio, M.V. & Croce, C.M. (2012). microRNA involvement in human cancer. Carcinogenesis, 33(6): 1126-1133. DOI «https://doi.org/10.1093/carcin/bgs140» DOI: https://doi.org/10.1093/carcin/bgs140
Jankovic, J. (2008). Parkinson's disease: clinical features and diagnosis. Journal of neurology, neurosurgery, and psychiatry, 79(4): 368-376. DOI «https://doi.org/10.1136/jnnp.2007.131045» DOI: https://doi.org/10.1136/jnnp.2007.131045
Landrier, J.F.; Derghal, A. & Mounien, L. (2019). MicroRNAs in obesity and related metabolic disorders. Cells, 8(8): 859. DOI «https://doi.org/10.3390/cells8080859» DOI: https://doi.org/10.3390/cells8080859
Lawrence, E. (Comp.). (2014). Diccionario de Biología, (Trad. Henderson’s Dictionary of Biology; p. 622). México: Editorial Trillas. ISBN 978-607-17-2057-3
Lawrence, E. (Edit.). (2003). Diccionario Akal de Términos Biológicos, (12va ed.; Henderson’s Dictionary of Biological Terms; R. Codes Valcarce & Fco. J. Espino Nuño, Trad.; p. 688). Madrid, España: Ediciones Akal. ISBN 84-460-1582X.
Lee, R.C.; Feinbaum, R.L. & Ambros, V. (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 75(5): 843-854. DOI «https://doi.org/10.1016/0092-8674(93)90529-Y» DOI: https://doi.org/10.1016/0092-8674(93)90529-Y
Lee, Y.S. & Dutta, A. (2009). MicroRNAs in cancer. Annual review of pathology, 4: 199-227. DOI «https://doi.org/10.1146/annurev.pathol.4.110807.092222» DOI: https://doi.org/10.1146/annurev.pathol.4.110807.092222
Long, H.; Wang, X.; Chen, Y.; Wang, L.; Zhao, M. & Lu, Q. (2018). Dysregulation of microRNAs in autoimmune diseases: pathogenesis, biomarkers and potential therapeutic targets. Cancer Letters, 428: 90-103. DOI «https://doi.org/10.1016/j.canlet.2018.04.016» DOI: https://doi.org/10.1016/j.canlet.2018.04.016
Lu, T.X. & Rothenberg, M.E. (2018). MicroRNA. Journal of Allergy and Clinical Immunology, 141(4): 1202-1207. DOI «https://doi.org/10.1016/j.jaci.2017.08.034» DOI: https://doi.org/10.1016/j.jaci.2017.08.034
McGuire, A.; Brown, J.A.L. & Kerin, M.J. (2015). Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring. Cancer Metastasis Reviews, 34(1): 145-155. DOI «https://doi.org/10.1007/s10555-015-9551-7» DOI: https://doi.org/10.1007/s10555-015-9551-7
Milevskiy, M.J.G.; Gujral, U.; Del Lama Marques, C.; Stone, A.; Northwood, K.; Burke, L.J.; Gee, J.M.W.; Nephew, K. Clark, S. & Brown, M.A. (2019). MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancer. British Journal of Cancer, 120: 621-632. DOI «https://doi.org/10.1038/s41416-019-0395-8» DOI: https://doi.org/10.1038/s41416-019-0395-8
Miñones-Moyano, E.; Porta, S.; Escaramís, G.; Rabionet, R.; Iraola, S.; Kagerbauer, B.; Espinosa-Parrilla, Y.; Ferrer, I.; Estivill, X. & Martí, E. (2011). MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function. Human Molecular Genetics, 20(15): 3067-3078. DOI «https://doi.org/10.1093/hmg/ddr210» DOI: https://doi.org/10.1093/hmg/ddr210
Nahand, J.S.; Taghizadeh-boroujeni, S.; Karimzadeh, M.; Borran, S.; Pourhanifeh, M.H.; Moghoofei, M.; Bokharaei-Salim, F.; Karampoor, S.; Jafari, A.; Asemi, Z.; Tbibzadeh, A.; Namdar, A. & Mirzaei, H. (2019). microRNAs: new prognostic, diagnostic, and therapeutic biomarkers in cervical cancer. Journal of Cellular Physiology, 234(10): 17064-17099. DOI «https://doi.org/10.1002/jcp.28457» DOI: https://doi.org/10.1002/jcp.28457
Nies, Y.H.; Mohamad Najib, N.H.; Lim, W.L.; Kamaruzzaman, M.A.; Yahaya, M.F. & Teoh, S.L. (2021). MicroRNA Dysregulation in Parkinson's disease: a narrative review. Frontiers in Neuroscience, 15: 660379. DOI «https://doi.org/10.3389/fnins.2021.660379» DOI: https://doi.org/10.3389/fnins.2021.660379
O'Brien, J.; Hayder, H.; Zayed, Y. & Peng, C. (2018). Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Frontiers in Endocrinology, 9: 402. DOI «https://doi.org/10.3389/fendo.2018.00402» DOI: https://doi.org/10.3389/fendo.2018.00402
Okada, C.; Yamashita, E.; Lee, S.J.; Shibata, S.; Katahira, J., Nakagawa, A.; Yoneda, Y. & Tsukihara, T. (2009). A high-resolution structure of the pre-microRNA nuclear export machinery. Science, 326(5957): 1275-1279. DOI «https://doi.org/10.1126/science.1178705» DOI: https://doi.org/10.1126/science.1178705
Shin, V.Y. & Chu, K.M. (2014). MiRNA as potential biomarkers and therapeutic targets for gastric cancer. World Journal of Gastroenterology, 20(30): 10432-10439. DOI «https://doi.org/10.3748%2Fwjg.v20.i30.10432» DOI: https://doi.org/10.3748/wjg.v20.i30.10432
Silvestro, S.; Bramanti, P. & Mazzon, E. (2019). Role of miRNAs in Alzheimer's disease and possible fields of application. International Journal of Molecular Sciences, 20(16): 3979. DOI «https://doi.org/10.3390/ijms20163979» DOI: https://doi.org/10.3390/ijms20163979
Smith, T.; Rajakaruna, C.; Caputo, M. & Emanueli, C. (2015). MicroRNAs in congenital heart disease. Annals of translational medicine, 3(21): 333. DOI «https://doi.org/10.3978/j.issn.2305-5839.2015.12.25»
Stypińska, B. & Paradowska-Gorycka, A. (2015). Cytokines and microRNAs as candidate biomarkers for systemic lupus erythematosus. International Journal of Molecular Sciences, 16(10): 24194-24218. DOI «https://doi.org/10.3390/ijms161024194» DOI: https://doi.org/10.3390/ijms161024194
Tomankova, T.; Petrek, M.; Gallo, J. & Kriegova, E. (2011). MicroRNAs: emerging regulators of immune-mediated diseases. Scandinavian Journal of Immunology, 75(2): 129-141. DOI «https://doi.org/10.1111/j.1365-3083.2011.02650.x» DOI: https://doi.org/10.1111/j.1365-3083.2011.02650.x
Tornesello, M.L.; Faraonio, R.; Buonaguro, L.; Annunziata, C.; Starita, N.; Cerasuolo, A.; Pezzuto, F.; Tornesello, A.L. & Buonaguro, F.M. (2020). The role of microRNAs, long non-coding RNAs, and circular RNAs in cervical cancer. Frontiers in Oncology, 10: 150. DOI «https://doi.org/10.3389/fonc.2020.00150» DOI: https://doi.org/10.3389/fonc.2020.00150
Vasu, S.; Kumano, K.; Darden, C.M.; Rahman, I.; Lawrence, M.C. & Naziruddin, B. (2019). MicroRNA Signatures as Future Biomarkers for Diagnosis of Diabetes States. Cells, 8(12): 1533. DOI «https://doi.org/10.3390/cells8121533» DOI: https://doi.org/10.3390/cells8121533
Yoda, M.; Kawamata, T.; Paroo, Z.; Ye, X.; Iwasaki, S.; Liu, Q. & Tomari, Y. (2010). ATP-dependent human RISC assembly pathways. Nature Structural & Molecular Biology, 17: 17-23. DOI «https://doi.org/10.1038/nsmb.1733» DOI: https://doi.org/10.1038/nsmb.1733
Zampetaki, A.; Kiechl, S.; Drozdov, I.; Willeit, P.; Mayr, U.; Prokopi, M.; Mayr, A.; Weger, S.; Oberhollenzer, F.; Bonora, E.; Shah, A.; Willeit, J. & Mayr, M. (2010). Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circulation research, 107(6): 810-817. DOI «https://doi.org/10.1161/circresaha.110.226357 DOI: https://doi.org/10.1161/CIRCRESAHA.110.226357
Zhang, B.; Pan, X.; Cobb, G.P. & Anderson, T.A. (2007). microRNAs as oncogenes and tumor suppressors. Developmental biology, 302(1): 1-12. DOI «https://doi.org/10.1016/j.ydbio.2006.08.028» DOI: https://doi.org/10.1016/j.ydbio.2006.08.028
Zhang, H.; Kolb, F.A.; Jaskiewicz, L.; Westhof, E. & Filipowicz, W. (2004). Single processing center models for human dicer and bacterial RNase III. Cell, 118(1): 57-68. DOI «https://doi.org/10.1016/j.cell.2004.06.017» DOI: https://doi.org/10.1016/j.cell.2004.06.017
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Kuxulkab'
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
- Los autores que publiquen en Kuxulkab' aceptan las siguientes condiciones como política de acceso abierto:
- Que conservan los derechos de autor y ceden a la revista el derecho de la primera publicación, con el trabajo registrado con la licencia de atribucion de "Creative Commons", que permite a terceros utilizar lo publicado siempre que mencionen la autoría del trabajo y a la primera publicación en esta revista.
- El autor puede realizar otros acuerdos contractuales independientes o adicionales para la distribución no exclusiva de la versión del artículo publicado en esta revista, como por ejemplo incluirlo en un repositorio institucional o publicarlo en un libro, siempre que se indique claramente que el trabajo se publicó por primera vez en esta revista.
